This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 2.65 points to 1,008.24 Monday. Today, two medical marijuana companies, Bedrocan Cannabis Corp. (BED) and OrganiGram Holdings Inc. (OGI), started trading. Technically, OrganiGram was not a shell company; this is just a change of business.

Bedrocan was the third most active stock on the TSX-V. It opened at $1.25, shot up to $1.45, fell back to $1 and then closed at $1.17 on 5.57 million shares. Bedrocan sold an $11.47-million private placement at 85 cents in connection with its going-public transaction. Those subscribers are up about 37 per cent. The IPO shareholders of Pat DiCapo's capital pool, POCML 2 Inc. (PCC), which Bedrocan used to go public, have done much better. The shell sold its IPO at 15 cents in May, 2013. The IPO shares were rolled back 1:2 as part of the QT, making each share worth a postconsolidated 30 cents and giving IPO shareholders a return of nearly 400 per cent. Shell packager Mr. DiCapo has already started the paperwork for a new capital pool shell, POCML 3 Inc., but he has yet to file the preliminary prospectus.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS